High mortality among older patients treated with pentavalent antimonials for visceral leishmaniasis in East Africa and rationale for switch to liposomal amphotericin B

Antimicrob Agents Chemother. 2011 Jan;55(1):455-6. doi: 10.1128/AAC.01298-10. Epub 2010 Nov 15.
No abstract available

Publication types

  • Letter

MeSH terms

  • Africa
  • Age Factors
  • Amphotericin B / therapeutic use*
  • Antiprotozoal Agents / therapeutic use*
  • Humans
  • Leishmaniasis, Visceral / drug therapy*
  • Leishmaniasis, Visceral / mortality*
  • Middle Aged

Substances

  • Antiprotozoal Agents
  • liposomal amphotericin B
  • Amphotericin B